Croce v. N.Y. Times Co.

345 F. Supp. 3d 961
CourtDistrict Court, S.D. Ohio
DecidedNovember 6, 2018
DocketCase No. 2:17-cv-402
StatusPublished
Cited by16 cases

This text of 345 F. Supp. 3d 961 (Croce v. N.Y. Times Co.) is published on Counsel Stack Legal Research, covering District Court, S.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Croce v. N.Y. Times Co., 345 F. Supp. 3d 961 (S.D. Ohio 2018).

Opinion

C. Glanz Sends the Letter

Glanz did get in touch. After making several public-records requests, Glanz sent the Letter on New York Times letterhead to Ohio State and Dr. Croce on November 23, 2016. The Letter stated that Glanz had questions he wanted to "put urgently" to Dr. Croce and Ohio State as part of an article he was preparing. (Id. at ¶ 50). The Letter requested answers to 25 paragraphs' worth of questions.

Dr. Croce alleges that the Letter contained several defamatory statements. The Letter raised various accusations against Dr. Croce, many of which were Glanz's representations of what others in the scientific community had said. For example, the Letter stated that a "Dr. Sanders argues ... that Dr. Croce is knowingly engaging in scientific misconduct and fraud. Does Dr. Croce disagree with this allegation, and if so, why[?]" (Am. Compl., Ex. A at PAGEID 679).

D. Dr. Croce Responds

Dr. Croce retained legal counsel to respond to Glanz's letter. He responded point-by-point to the Letter, as he says, refuting the false and defamatory allegations in the Letter. Dr. Croce also requested information supporting some of the statements made in the Letter, but Glanz did not respond to those requests.

*972On January 26, 2017, Glanz sent an email to Dr. Croce's counsel posing two additional questions, to which Dr. Croce responded. Dr. Croce then asked Glanz to cite and explain any inaccuracies in Dr. Croce's earlier responsive letter and to provide information that Dr. Croce had earlier requested. Glanz again did not respond. On March 2 and 3, 2017, the two sides exchanged a third round of correspondence, which ended similarly, without a response from Glanz to Dr. Croce's questions.

E. The New York Times Publishes the Article

On March 8, 2017, the New York Times published the Article on the front page of its digital version under this headline: "Years of Ethics Charges, but Star Cancer Researcher Gets a Pass. Dr. Carlo Croce was repeatedly cleared by Ohio State University, which reaped millions from his grants. Now, he faces new whistle-blower accusations." (Am. Compl. at ¶ 76). The next day, the Article "was published on the front page of the New York Times' print version, above the fold, under the headline 'Years of Questions but Researcher Gets a Pass.' " (Id. at ¶ 78). The Article was "Number One on the list of 'Most Popular' articles in the digital version of The New York Times." (Id. at ¶ 80). The Article quickly garnered over 400 comments online.

The Times also advertised the Article on Twitter and Facebook under another headline: "A star cancer researcher accused of fraud was repeatedly cleared by Ohio State, which reaps millions from his grants." (Id. at ¶ 77). Glanz posted the article to his own Twitter page as well.

The Article is substantial in length, comprising over 14 pages and about 90 paragraphs in the version submitted as an attachment to the Amended Complaint. The Court will discuss below the specific statements in the Article which are alleged to be defamatory. But generally speaking, the Article describes Dr. Croce as a "prolific" scientist who "parlayed his decades-long pursuit of cancer remedies into a research empire." (Id. , Ex. C at PAGEID 87). The Article reports on the "quotient of controversy" which has become attached to Dr. Croce, specifically "allegations of data falsification other scientific misconduct." (Id. ). The claims made by Dr. Croce's critics are recounted, as is Dr. Croce's response denying any wrongdoing. Varying explanations (from critics, Dr. Croce and other observers) are offered for the alleged bad data and errors-ranging from "falsification" to "reckless disregard" to "sloppiness" to "honest errors." The Article reports that Dr. Croce has not been sanctioned for misconduct by any oversight agencies or by Ohio State, which cleared him in at least five cases. The Article raises the concern that Ohio State has a financial incentive to overlook problems with Dr. Croce's work, but it adds a statement from Ohio State saying that the University evaluates complaints of misconduct on the merits and without regard to a researcher's grant money.

F. Glanz Gives the Interview to a Columbus PBS Affiliate

Glanz publicly commented on the Article too. Glanz was interviewed by WOSU Radio on March 9, 2017. He made the following statement in the Interview:

"Well, the allegations are that in the lab he oversees and on papers which he is co-author, there are-call them fabricated figures. They're duplications of data from unrelated experiments used to prove a point you know in another experiment. I think that's probably at the center of things and then there's some other ethics charges including plagiarism *973and misappropriation of grant money and things like that, but it's really the data manipulation that's at the center of the allegations."

(Am. Compl., Ex. D. at PAGEID 723-24).

G. Dr. Croce Sues

On May 10, 2017, Dr. Croce sued the New York Times Company and four of its employees: (1) Glanz, (2) Agustin Armendariz, whose name appeared as a co-author of the Article, (3) Arthur Ochs Sulzberger Jr., the publisher of the New York Times and (4) Dean Baquet, the executive editor of the New York Times. Dr. Croce asserts state law claims for defamation, false light and intentional infliction of emotional distress. He alleges that:

having his scientific integrity falsely maligned is devastating. To have his integrity falsely impugned in a front-page article in the New York Times that is instantly distributed to millions throughout the world is crushing. The harm inflicted by false accusations of scientific misconduct has far-reaching effects, not only for Dr. Croce, but also for the scientists who have worked with him.

(Id. at ¶ 245).

Dr. Croce further alleges he has lost weight and sleep because "he is embarrassed by the fact that millions of people worldwide have read an article that so falsely maligns not only him, as a scientist and as a person, but also maligns his life's work." (Id. at ¶ 252). He outlines several ways in which he has suffered pecuniary harm too, including no longer being asked to serve as an expert witness in patent litigation and losing out on an invitation to sit on a selection panel in Europe for an annual scientific prize.

II. Legal Standard

A defendant may move to dismiss a claim for "failure to state a claim upon which relief can be granted." Fed. R. Civ. P. 12(b)(6). The Court will deny the motion to dismiss if the complaint "contain[s] sufficient factual matter, accepted as true, to 'state a claim to relief that is plausible on its face.' " Ashcroft v. Iqbal , 556 U.S. 662, 678, 129 S.Ct. 1937

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
345 F. Supp. 3d 961, Counsel Stack Legal Research, https://law.counselstack.com/opinion/croce-v-ny-times-co-ohsd-2018.